Clinical Trial Update: Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes

View source ↗

Summary

Completed clinical trial evaluating anti-AT1 receptor antibodies and kidney transplant outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Failure
• Kidney Transplant Rejection

Drugs mentioned

• Anti-angiotensin II type 1 receptor antibody (anti-AT1 receptor antibody)

Snippet

Sponsor: Paris Translational Research Center for Organ Transplantation | Conditions: Kidney Transplant Failure and Rejection | Status: COMPLETED